Uguz, FarukSonmez, Erdem Onder2024-02-232024-02-2320130163-83431873-7714https://doi.org/10.1016/j.genhosppsych.2012.11.004https://hdl.handle.net/20.500.12452/11927Neuroleptic malignant syndrome (NMS) is a rarely observed life-threatening medical condition due mostly to antipsychotic use. Additionally, a few case reports have suggested an association between NMS and the use of selective serotonin reuptake inhibitors (SSRIs) alone or in combination with antipsychotics. This case report presents a female patient developing NMS following the use of a combination of sertraline and paroxetine. (C) 2013 Elsevier Inc. All rights reserved.eninfo:eu-repo/semantics/closedAccessAntidepressantsNeuroleptic Malignant SyndromeSertralineParoxetineEditorial Material353233121452-s2.0-84876999247Q1WOS:000318995800023Q210.1016/j.genhosppsych.2012.11.004